Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Cytomegalovirus vaccine development
M. R. Schleiss
Pediatric Infectious Diseases
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
76
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cytomegalovirus vaccine development'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Childbearing Women
12%
Clinical Trials
25%
Congenital Infection
12%
Cytomegalovirus Disease
12%
Cytomegalovirus Infection
12%
Cytomegalovirus Vaccine
100%
Disease Severity
12%
Fetus
25%
Haematopoietic Stem Cell Transplant Recipients
12%
High Risk
12%
High-risk Areas
12%
HIV Infection
12%
Host Immune Response
12%
Human Cytomegalovirus
100%
Immune Correlates
12%
Immunocompromised Patients
12%
Lay Public
12%
Licensure
12%
Protective Immunity
12%
Public Health Risk
12%
Solid Organ
12%
Vaccination
12%
Vaccine Development
100%
Viral Proteins
12%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
22%
Congenital Infection
11%
Cytomegalovirus Infection
22%
Cytomegalovirus Vaccine
100%
Disease
22%
Human Cytomegalovirus
100%
Human Immunodeficiency Virus Infection
11%
Immunocompromised Patient
11%
Infection
11%
Vaccine Development
100%
Viral Protein
11%
Immunology and Microbiology
Cytomegalovirus Infection
11%
Cytomegalovirus Vaccine
100%
Hematopoietic Stem Cell Transplantation
11%
Human Cytomegalovirus
100%
Human Immunodeficiency Virus Infection
11%
Immunity
11%
Immunocompromised Patient
11%
Pregnancy
11%
Viral Protein
11%